ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Program Announcements Non-Invasive Detection Of Lung Cancer

April 15, 1983

Pitot Supports Clearinghouse Modifications

January 20, 1978

More Oncopathology Research Asked

June 30, 1978

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002

Senate Markup Of Labor-HSS-Education Money Bill Delayed Until After Congress August Recess

August 4, 1989